Eledon Pharmaceuticals Inc (ELDN)

Currency in USD
3.810
+0.100(+2.70%)
Closed·
After Hours
3.800-0.010(-0.26%)
·
ELDN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 14 days
Fair Value
Day's Range
3.6903.850
52 wk Range
2.3755.540
Key Statistics
Prev. Close
3.71
Open
3.79
Day's Range
3.69-3.85
52 wk Range
2.375-5.54
Volume
349.14K
Average Volume (3m)
416.32K
1-Year Change
21.73%
Book Value / Share
1.91
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ELDN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
9.000
Upside
+136.22%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings upwards for the upcoming period

Eledon Pharmaceuticals Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Eledon Pharmaceuticals Inc Company Profile

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for the prevention of allograft rejection in kidney transplantation and xenotransplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.

Compare ELDN to Peers and Sector

Metrics to compare
ELDN
Peers
Sector
Relationship
P/E Ratio
−12.0x−5.7x−0.5x
PEG Ratio
−0.130.020.00
Price/Book
2.0x3.8x2.6x
Price / LTM Sales
-247.8x3.2x
Upside (Analyst Target)
142.6%133.1%41.9%
Fair Value Upside
Unlock6.4%4.3%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 9.000
(+136.22% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.08 / -0.25
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ELDN Income Statement

People Also Watch

6.820
CAPR
+4.60%
2.080
OTLK
0.00%
6.070
AGEN
-0.82%
86.75
CIEN
+2.83%
2.66
ANVS
+3.50%

FAQ

What Stock Exchange Does Eledon Pharmaceuticals Trade On?

Eledon Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Eledon Pharmaceuticals?

The stock symbol for Eledon Pharmaceuticals is "ELDN."

What Is the Eledon Pharmaceuticals Market Cap?

As of today, Eledon Pharmaceuticals market cap is 222.16M.

What Is Eledon Pharmaceuticals's Earnings Per Share (TTM)?

The Eledon Pharmaceuticals EPS (TTM) is -0.32.

When Is the Next Eledon Pharmaceuticals Earnings Date?

Eledon Pharmaceuticals will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is ELDN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Eledon Pharmaceuticals Stock Split?

Eledon Pharmaceuticals has split 2 times.

How Many Employees Does Eledon Pharmaceuticals Have?

Eledon Pharmaceuticals has 31 employees.

What is the current trading status of Eledon Pharmaceuticals (ELDN)?

As of 24 Jul 2025, Eledon Pharmaceuticals (ELDN) is trading at a price of 3.81, with a previous close of 3.71. The stock has fluctuated within a day range of 3.69 to 3.85, while its 52-week range spans from 2.38 to 5.54.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.